...
机译:Nonclinical safety evaluation of two vaccine candidates for herpes simplex virus type 2 to support combined administration in humans
Merck & Co., Inc.;
Immune Design Corp., Seattle, WA, USA, a wholly owned subsidiary of Merck & Co., Inc.;
Sanofi;
G103 vaccine; genital herpes; GLA‐SE adjuvant; HSV‐2; HSV529 vaccine; live attenuated virus vaccine; nonclinical safety evaluation; prime‐boosting; vaccine;